Bronchiectasis and Disability Benefits

Bronchiectasis involves damaged, widened airways that have difficulty clearing mucus. Repeated infections and the daily work of managing secretions can interrupt activity, but the impact differs between people. A disability claim should show both the underlying lung damage and the pattern of symptoms, treatment and recovery.

How SSA Evaluates Bronchiectasis

SSA requires imaging to document bronchiectasis. Listing 3.07 addresses exacerbations or complications requiring at least three hospitalizations within a 12-month period, at least 30 days apart. Each hospitalization must last at least 48 hours, counting time in an emergency department immediately before admission. The 12-month period must fall within the period SSA is evaluating for the application or continuing disability review. Outpatient antibiotic courses do not become hospital admissions simply because they were intensive.

SSA also evaluates bronchiectasis under listing 3.02 for chronic respiratory disorders, which has separate pulmonary-function, gas-exchange and hospitalization alternatives with technical requirements. When no listing is met or medically equaled, SSA evaluates residual functional capacity and the ability to do past or other work, considering age, education and experience.

For adult disability-based SSDI and SSI, the impairment must prevent substantial gainful activity for at least 12 continuous months, be expected to last that long, or be expected to result in death. SSDI has insured-work requirements; SSI has financial and other eligibility rules.

Build an Episode Record That Can Be Checked

• Identify the chest imaging that established airway damage and the pulmonologist’s interpretation.
• Provide available lung-function reports, sputum cultures and assessments of underlying or accompanying conditions.
• List admission and discharge dates, the reason for each hospitalization and treatment received.
• Separately record infections managed at home, in a clinic or through home infusion, including their duration and effects.

NHLBI describes chest CT as a key diagnostic test and notes that a routine chest X-ray may not detect bronchiectasis except in extreme cases. Give SSA existing records rather than assuming a normal X-ray resolves the diagnosis. Testing decisions remain with the treating clinician.

Account for Airway Clearance and Recovery

A work history should describe more than how far you can walk. Explain coughing episodes that interrupt speaking or tasks, time spent clearing secretions, fatigue after infections and the need to pause physical activity. If your prescribed care takes time during the day, describe the actual schedule and whether it can be shifted. Do not assume a particular treatment duration or number of breaks automatically establishes inability to work.

Include stable weeks as well as exacerbations. Record whether you return to your previous level of activity after an infection and how long that takes. If COPD, cystic fibrosis or another condition contributes, make the diagnoses and combined limitations clear instead of treating their listing rules as interchangeable.

Treatment and Access Barriers

NHLBI describes airway-clearance techniques, medicines directed at infection or mucus, and treatment of the underlying cause. Selected people need oxygen or procedures. The care plan is individualized; this guide does not teach a clearance technique, recommend an antibiotic or prescribe fluids.

For benefits evidence, include the actual plan, equipment, medication changes and response. Report side effects you experience and the clinician’s response. Explain difficulty obtaining equipment, medicines, home support or appointments. Keep evidence of cost and coverage barriers and efforts to obtain care.

SSA’s failure-to-follow-treatment policy is narrower than a rule that any missed care causes denial. It requires an otherwise qualifying claim and relevant treatment prescribed by the person’s own medical source, among other conditions. SSA assesses whether following it would restore substantial gainful activity and whether the person has good cause for not doing so.

Do Home IV Antibiotics Count Under Listing 3.07?

They are important treatment evidence, but home infusions do not satisfy that listing’s hospital-admission requirement. They can still help explain disease severity, treatment burden and functioning under the broader evaluation.

Application and Approval Guidance

If denied, compare the decision with the actual imaging, episode dates and functional record. The reviewed sources do not establish a current personal approval rate for bronchiectasis. Statistics combining different respiratory disorders cannot predict a claim with a different admission history and treatment response. Read the approval-data guide before using a percentage.

Next Steps and Sources

Use the application guide and medical and work records checklist. If you have a decision, read its reasons and deadlines alongside the appeals guide.

Related reading: COPD, cystic fibrosis. Browse the condition directory.

Official Sources

• 3.00 – Respiratory – Adult^[1]
• Bronchiectasis – What Is Bronchiectasis?
• Bronchiectasis – Diagnosis
• Bronchiectasis – Treatment
• Part I – General Information^[2]
• How Does Someone Become Eligible?^[3]
• Code of Federal Regulations § 404.1545^[4]
• Part II – Evidentiary Requirements^[5]
• SSR 18-3p^[6]

General educational information, not individualized medical or legal advice. Disability Benefit Guide USA is not affiliated with the Social Security Administration. Read how our guides are prepared.

Official Sources and References

These SSA.gov links support the explanations above. Official applications, account services, and agency forms are completed through SSA.

1. 3.00 – Respiratory – Adult — SSA.gov
2. Part I – General Information — SSA.gov
3. How Does Someone Become Eligible? — SSA.gov
4. Code of Federal Regulations § 404.1545 — SSA.gov
5. Part II – Evidentiary Requirements — SSA.gov
6. SSR 18-3p — SSA.gov